Toll-like receptor expression in normal ovary and ovarian tumors - Wikidata - awgldk - TriplyDB

Toll-like receptor expression in normal ovary and ovarian tumors

Toll-like receptor expression in normal ovary and ovarian tumors

http://www.wikidata.org/entity/Q28307970

about

Mucins and toll-like receptors: kith and kin in infection and cancer Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical lesions and their correlation with HPV16 infection in Uighur women.WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3 The same and not the same: heterogeneous functional activation of prostate tumor cells by TLR ligation LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4 Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma.Toll-like receptors expression in follicular cells of patients with poor ovarian response Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Activation of dendritic cells by the novel Toll-like receptor 3 agonist RGC100.TLR4 activates NF-κB in human ovarian granulosa tumor cells.Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer Toll-like receptor 4 activation in cancer progression and therapy Inherited variation in pattern recognition receptors and cancer: dangerous liaisons?Toll-like receptors as novel therapeutic targets for ovarian cancer.MiRNA-149 modulates chemosensitivity of ovarian cancer A2780 cells to paclitaxel by targeting MyD88 Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9 Expression and significance of the TLR4/MyD88 signaling pathway in ovarian epithelial cancers.Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma Immune regulation of ovarian development: programming by neonatal immune challenge.The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer.Innate immunity in the human endometrium and ovary.Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.Toll-like receptors in urothelial cells--targets for cancer immunotherapy.Treatment of Neuroblastoma with an Engineered "Obligate" Anaerobic Salmonella typhimurium Strain YB1.KDM3A promotes inhibitory cytokines secretion by participating in TLR4 regulation of Foxp3 transcription in lung adenocarcinoma cells.The dual role of TLR3 in metastatic cell line.Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response.Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression Polyinosinic-Polycytidylic Acid Perturbs Ovarian Functions Through Toll-Like Receptor 3-Mediated Tumor Necrosis Factor A Production in Female Mice.Neonatal immune activation depletes the ovarian follicle reserve and alters ovarian acute inflammatory mediators in neonatal rats.P-MAPA immunotherapy potentiates the effect of cisplatin on serous ovarian carcinoma through targeting TLR4 signaling.Poly (I:C) and LPS induce distinct immune responses by ovarian stromal fibroblasts.The Role of Toll-Like Receptor in Inflammation and Tumor Immunity Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer

P2860

Q26830597-7F2E5534-41EC-4469-87BE-CF926DFD6C36 Q26861234-9DC40E6A-DBE8-4ACC-914A-F3AA16648265 Q33579661-5B9E2FB0-F91E-47B4-8479-5F39780824CA Q33634911-F99C2861-BEF1-4DC3-948B-DD7E21FE3FF2 Q33801246-A28C5A5D-3D93-4023-A6E4-2DBE737465CA Q33824394-82998F48-BA94-4BAE-A522-04DDEAA7F1D7 Q33920568-B7CEE559-6637-4545-B77F-E7BEA1B1A255 Q33937289-6E4CE714-AC52-4666-BD8C-2019A54ED514 Q34022013-8102B9E1-EE64-4F57-9C9E-764936553314 Q34399608-9DDE131E-3354-444C-8038-5D11D94453D8 Q35056554-E40E26E2-FA90-4939-A613-A7C28092756A Q35066004-F32DF307-B9E5-49D6-9E91-A073884F1955 Q35550677-BB0C7F3E-F64A-428A-9230-6ADE3F1C4269 Q35832150-CCD11FFF-F66C-4126-B315-9E3D36552C96 Q35864309-0423E0D5-6661-46FA-BD79-93E309993ADC Q35902797-D9AF9B61-55D4-4E2E-AC05-75CD3E0D9F49 Q36127825-33A42DA9-3A1A-42B0-A2EA-F2FB1A763793 Q36151692-CF5EF5DF-29A8-4E4D-BCCE-D284B74DD1A9 Q36517552-C40522CC-DD63-4B0F-AD16-D2FA0414C01F Q36842192-2FA4B086-C8C4-4DE3-91BD-45B8EB04E6B5 Q36884862-8D4C87DB-A2A6-4DBA-B988-2D73AE3CBD14 Q36920850-F633BC4E-5BC8-407C-B512-FD53EF54E3E6 Q37396607-65E167BD-52B5-4F7D-8BED-A4AD6DBC54DB Q37506796-B1CEF2AC-31AB-46DF-8B25-153C940326E2 Q37730044-6DFA236B-B80D-4C69-B346-97630A0F6804 Q37739809-9B3920BA-F246-4AC0-B7A6-3EA6F30F7A80 Q37897264-697DA4F2-1B70-4D0C-A02A-ED02AD398EBC Q38039958-3D0EDA36-7073-4757-8110-A323DE48C80B Q38131726-BF0F04E2-95D9-4580-A19B-388F924E9F28 Q38647098-7E787980-3051-4A53-9AC9-6158478C21E0 Q38703026-8A285DBA-A960-4550-AEBD-2924768A2FC0 Q39511419-E5F4696D-F265-4B13-ACE8-B5C42910F2DF Q40516283-402F1E39-4255-4824-8913-8F9D96274836 Q40923346-CEB1C5BD-65D4-4C67-98C4-DDFF1EAA7144 Q41187032-7D31DA68-4B16-4430-84E9-15D529CC6810 Q47595314-975CDE60-2794-4A2E-89DA-A10F7FE829D2 Q48533544-20F3808C-B106-4A23-A134-8C5876A77FFE Q54212481-E4DA66BF-7308-494A-8E54-5973A480A2D5 Q57170572-D496F42C-BB58-419C-B9D3-DF7417BDA62B Q58423073-2CCC3ED6-AE05-4129-ACFB-CEA6898975DB

P2860

Toll-like receptor expression in normal ovary and ovarian tumors

http://www.wikidata.org/entity/Q28307970

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Toll-like receptor expression in normal ovary and ovarian tumors

@ast

Toll-like receptor expression in normal ovary and ovarian tumors

@en

Toll-like receptor expression in normal ovary and ovarian tumors

@nl

type

label

Toll-like receptor expression in normal ovary and ovarian tumors

@ast

Toll-like receptor expression in normal ovary and ovarian tumors

@en

Toll-like receptor expression in normal ovary and ovarian tumors

@nl

prefLabel

Toll-like receptor expression in normal ovary and ovarian tumors

@ast

Toll-like receptor expression in normal ovary and ovarian tumors

@en

Toll-like receptor expression in normal ovary and ovarian tumors

@nl

P1433

Q28307970-D503B92F-2FD7-40E2-A44E-6589B5566727

P1476

Q28307970-D42D3A7F-F1F7-42BB-B169-64E3D7A74820

P2093

Q28307970-262C8E63-EE93-424B-833C-FE0AD009BFC3

Q28307970-6491FE85-3D12-44BC-8378-21A5DC445295

Q28307970-67A97696-EC64-4A2D-B98A-ED8F12C82A6E

Q28307970-A2A00C9C-1F0F-40C1-801B-0E3A8011149D

Q28307970-BC6732A0-7198-41A9-A4B6-E8973CA832CE

Q28307970-CEB9655F-AC03-489D-BB1F-F4022D152D27

P2860

Q28307970-0BF7A2CE-ADE0-4C0F-A6E3-68ED09B13C92

Q28307970-12EFC399-8722-4A19-AE74-1619A288B56A

Q28307970-142CD8E8-1020-4BB7-829D-917C1816B2D3

Q28307970-1D0B3EE8-E9CA-4A51-B7B6-BEEA5C8BDD67

Q28307970-69FBC9EF-7B9F-4A8C-B1ED-CB3CE9E0AAD5

Q28307970-7466BB37-36B3-4F01-AA2D-6019CB3F3837

Q28307970-CB320D8D-E87A-4B16-AAC2-A0322841DDDB

P2888

Q28307970-8FA72F83-48A6-44A0-9762-9103A24726D7

P304

Q28307970-C1100A4B-D9A9-42C7-8A52-E3FAD5F88E36

P31

Q28307970-FDFFE49F-30B1-4124-A62C-5EA320745D73

P3181

Q28307970-F3D01AF6-F4A0-4C8A-BFC8-E39173E40384

P356

Q28307970-EC96B9CB-67D7-43C1-B34C-62FC4A860BAC

P407

Q28307970-0243DA44-D7A6-41C0-98BD-7F8EC8D6C512

P433

Q28307970-DC444101-ED5E-4A00-9813-B7F17EF93342

P478

Q28307970-2FBACFAF-D12F-4950-9E3B-5E04B54733DF

P577

Q28307970-73A548B4-8147-470D-B488-C6C3ABD27E7F

P6179

Q28307970-F7364A2B-1476-458A-8FE1-A68701AF69A2

P698

Q28307970-FCB1AC14-3639-4387-AB39-3E2E69C2E42A

P921

Q28307970-D8EA1345-22B9-42E2-832E-9E807C4B4F34

P3181

P356

S00262-008-0650-Y

P1433

Cancer Immunology, Immunotherapy

P1476

Toll-like receptor expression in normal ovary and ovarian tumors

@en

P2093

Angela F Drew

http://www.w3.org/2001/XMLSchema#string

Holly M Funk

http://www.w3.org/2001/XMLSchema#string

Mingfu Zhou

http://www.w3.org/2001/XMLSchema#string

Molly M McFarland-Mancini

http://www.w3.org/2001/XMLSchema#string

Nader Husseinzadeh

http://www.w3.org/2001/XMLSchema#string

Taofic Mounajjed

http://www.w3.org/2001/XMLSchema#string

P2860

Lambda-interacting protein, a novel protein that specifically interacts with the zinc finger domain of the atypical protein kinase C isotype lambda/iota and stimulates its kinase activity in vitro and in vivo

Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype.

Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material.

Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion.

Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer.

Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling.

Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

P2888

s00262-008-0650-y

P304

1375-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2062912

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00262-008-0650-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052637429

http://www.w3.org/2001/XMLSchema#string

P698

19184006

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor